BNTX
Biontech Se
$111.77
Earnings Summary
Revenue | $128.7Mn |
Net Profits | $-807.8Mn |
Net Profit Margins | -627.66% |
Highlights
Biontech Se’s revenue fell -85.62% since last year same period to $128.7Mn in the Q2 2024. On a quarterly growth basis, Biontech Se has generated -0.5% fall in its revenue since last 3-months.
Biontech Se’s net profit fell -602.99% since last year same period to $-807.8Mn in the Q2 2024. On a quarterly growth basis, Biontech Se has generated 0.5% jump in its net profits since last 3-months.
Biontech Se’s net profit margin fell -3599.04% since last year same period to -627.66% in the Q2 2024. On a quarterly growth basis, Biontech Se has generated 0% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Biontech Se post its latest quarter earnings
EPS Estimate Current Quarter | -2.02 |
EPS Estimate Current Year | -2.02 |
Highlights
Biontech Se’s earning per share (EPS) estimates for the current quarter stand at -2.02 - a -72.65% fall from last quarter’s estimates.
Biontech Se’s earning per share (EPS) estimates for the current year stand at -2.02.
Key Ratios
Key ratios of the Biontech Se post its Q2 2024 earnings
Earning Per Share (EPS) | -3.36 |
Highlights
Biontech Se’s earning per share (EPS) fell -325.32% since last year same period to -3.36 in the Q2 2024. This indicates that the Biontech Se has generated -325.32% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-06 | -1.17 | -1.41 | -20.51% |
₹0 US Stocks a/c Opening Fee